Lung cancer

December 15, 2021

Ongoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spread

This study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
September 20, 2021

The language of (lung) cancer

A new language guide encourages respect, eliminates blame, and promotes health equity
September 20, 2021

Trial Results: Recent ECOG-ACRIN research

Summaries of recently reported ECOG-ACRIN research results
June 24, 2021

Trial Results: ECOG-ACRIN research round-up – Spring 2021

Summaries of recently reported ECOG-ACRIN research results